Guided care
A care decision starts with you.
A product can be compared by its published information. A prescription decision also needs your individual context. Health history, current medicines, the concern you want addressed, and the available alternatives shape what an appropriate next step looks like.
Explore the detailsIndividual context
Your history and current circumstances help a clinician interpret the concern you bring.
An informed decision
The proposed approach, expected benefits, possible risks, alternatives, and cost need a clear explanation.
Continuity
Follow-up, questions, reassessment, and any refill process belong in the plan from the beginning.
Prepare the history that matters.
Before an evaluation, organize the information that would help a clinician understand the concern. Include when it began, what you have already tried, your current medicines and supplements, allergies, relevant conditions, and your priorities. This site does not collect that information.
- Describe the concern and its timeline in your own words.
- Bring a complete list of medicines and supplements.
- Include previous treatment responses and relevant test results.
Clinical review can lead to different next steps.
An evaluation may lead to a treatment discussion, further testing, referral, an alternative approach, or no prescription. A catalog selection or a paid membership does not decide the outcome. The clinician should explain the reasoning and the product-specific information relevant to the proposal.
- Clarify the intended use and expected benefit.
- Discuss risks, interactions, and available alternatives.
- Ask what would lead to changing or stopping the proposed approach.
Understand the exact medicine and its status.
An FDA-approved medicine can sometimes be prescribed for an unapproved use, commonly called off-label use. That is different from a compounded product, which is not FDA-approved. Ask the clinician to explain the exact medicine, its status, and why it is being considered for your circumstances.
- Separate the name of a molecule from the finished product.
- Read the information for the proposed formulation and use.
- Discuss uncertainties rather than assuming products are equivalent.
Establish the follow-up before starting.
Ask who handles questions, how routine follow-up is arranged, how unexpected effects are reported, and when reassessment is required. Clinical review and recurring billing serve different roles. A successful renewal charge does not itself establish that continuing a treatment is appropriate.
- Confirm the scope and cost of follow-up.
- Clarify how reassessment and any refill decision work.
- Know where to seek urgent help; a routine online service is not emergency care.
Your questions, answered.
Is RA·NUE accepting assessments now?
No. Clinical assessments are not open. Provider identities, service scope, fees, eligibility, and access details must be published before a clinical service begins.
Can I choose a prescription directly from a health-goal page?
No. The health-goal pages are educational. They do not assess eligibility or make a prescription recommendation.
Sources & further reading.
General educational information from RA·NUE. These sources provide context; they do not validate a RA·NUE product or replace individual medical advice.